Mineralys Therapeutics Inc (MLYS) USD0.0001

Sell:$12.31Buy:$12.39$0.27 (2.14%)

NASDAQ:1.15%
Prices delayed by at least 15 minutes
Sell:$12.31
Buy:$12.39
Change:$0.27 (2.14%)
Prices delayed by at least 15 minutes
Sell:$12.31
Buy:$12.39
Change:$0.27 (2.14%)
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
20 June 2024
Jon CongletonCEO
Sell
Regular sell transaction (market)
14,940$11.73$175,237.24926,958
18 June 2024
Jon CongletonCEO
Sell
Regular sell transaction (market)
16,607$11.99$199,073.09941,898
17 June 2024
Jon CongletonCEO
Sell
Regular sell transaction (market)
17,766$12.25$217,711.67958,505
14 June 2024
Jon CongletonCEO
Sell
Regular sell transaction (market)
16,229$12.52$203,162.74976,271
13 June 2024
Jon CongletonCEO
Sell
Option/Award related
39,961$12.74$509,027.21992,500
12 June 2024
Jon CongletonCEO
Sell
Option/Award related
16,607$12.77$212,013.271,032,461
11 June 2024
Adam Scott LevyCFO
Sell
Option/Award related
96,815$12.94$1,252,718.33255,462
9 May 2024
David Malcom RodmanOther Level A
Sell
Option/Award related
100$15.00$1,500.0066,997
12 February 2024
SAMSARA BIOCAPITAL GP LLCVenture Capital
Buy
Regular purchase transaction
555,555$13.50$7,499,992.505,074,916
12 February 2024
RA CAPITAL MANAGEMENT LLCInvestment Management Company
Buy
Regular purchase transaction
1,672,508$13.50$22,578,858.002,983,755

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
12 February 2024
RA CAPITAL MANAGEMENT LLCInvestment Management Company
Buy
Regular purchase transaction
1,672,508$13.50$22,578,858.002,983,755
12 February 2024
SAMSARA BIOCAPITAL GP LLCVenture Capital
Buy
Regular purchase transaction
555,555$13.50$7,499,992.505,074,916
12 February 2024
RA CAPITAL MANAGEMENT LLCInvestment Management Company
Buy
Regular purchase transaction
549,755$13.50$7,421,142.75549,755
11 June 2024
Adam Scott LevyCFO
Sell
Option/Award related
96,815$12.94$1,252,718.33255,462
11 August 2023
David Malcom RodmanOther Level A
Sell
Option/Award related
80,909$12.81$1,036,444.290

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.